BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33347395)

  • 1. Co-delivery of cisplatin and doxorubicin by carboxylic acid functionalized poly (hydroxyethyl methacrylate)/reduced graphene nanocomposite for combination chemotherapy of breast cancer cells.
    Astani S; Salehi R; Massoumi B; Massoudi A
    J Biomater Sci Polym Ed; 2021 Apr; 32(5):657-677. PubMed ID: 33347395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System.
    Ghamkhari A; Abbaspour-Ravasjani S; Talebi M; Hamishehkar H; Hamblin MR
    Int J Biol Macromol; 2021 Feb; 169():521-531. PubMed ID: 33340628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convergent synthetic platform for dual anticancer drugs functionalized by reduced graphene nanocomposite delivery for hepatocellular cancer.
    Zhang Z; Su T; Han Y; Yang Z; Wei J; Jin L; Fan H
    Drug Deliv; 2021 Dec; 28(1):1982-1994. PubMed ID: 34569406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-Defined pH-Responsive Self-Assembled Block Copolymers for the Effective Codelivery of Doxorubicin and Antisense Oligonucleotide to Breast Cancer Cells.
    Mohamed MA; Yan L; Shahini A; Rajabian N; Jafari A; Andreadis ST; Wu Y; Cheng C
    ACS Appl Bio Mater; 2022 Oct; 5(10):4779-4792. PubMed ID: 36170623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe
    Gerami SE; Pourmadadi M; Fatoorehchi H; Yazdian F; Rashedi H; Nigjeh MN
    Int J Biol Macromol; 2021 Mar; 173():409-420. PubMed ID: 33454326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy.
    Dash BS; Lu YJ; Chen HA; Chuang CC; Chen JP
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112311. PubMed ID: 34474862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-grafted-poly(methacrylic acid)/graphene oxide nanocomposite as a pH-responsive de novo cancer chemotherapy nanosystem.
    Abbasian M; Roudi MM; Mahmoodzadeh F; Eskandani M; Jaymand M
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1871-1879. PubMed ID: 30017982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
    Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
    J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.
    Pei X; Zhu Z; Gan Z; Chen J; Zhang X; Cheng X; Wan Q; Wang J
    Sci Rep; 2020 Feb; 10(1):2717. PubMed ID: 32066812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of polymer functionalized graphene oxide system for breast cancer treatment.
    Vinothini K; Dhilip Kumar SS; Abrahamse H; Rajan M
    Int J Pharm; 2023 Feb; 632():122556. PubMed ID: 36584864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxymethyl cellulose/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent.
    Rasoulzadeh M; Namazi H
    Carbohydr Polym; 2017 Jul; 168():320-326. PubMed ID: 28457456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
    Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
    Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A perfect stimuli-responsive magnetic nanocomposite for intracellular delivery of doxorubicin.
    Ghamkhari A; Ghorbani M; Aghbolaghi S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S911-S921. PubMed ID: 30307331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green synthesized polyvinylpyrrolidone/titanium dioxide hydrogel nanocomposite modified with agarose macromolecules for sustained and pH-responsive release of anticancer drug.
    Pourmadadi M; Yazdian F; Koulivand A; Rahmani E
    Int J Biol Macromol; 2023 Jun; 240():124345. PubMed ID: 37054860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
    Javanbakht S; Pooresmaeil M; Namazi H
    Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.
    Hosseini Sadr S; Davaran S; Alizadeh E; Salehi R; Ramazani A
    J Biomater Sci Polym Ed; 2018 Feb; 29(3):277-308. PubMed ID: 29212412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
    Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.